The oncogenic potential of Epstein-Barr virus (EBV) in breast cancer is being increasingly recognized.
Despite some controversies regarding such role, new evidence is suggesting a culpability of EBV in breast cancer,
particularly in Africa where the virus has been originally associated with causation of several solid and
hematological malignancies. One example is a report from Sudan implicating EBV as a prime etiologic agent for an
aggressive type of breast cancer, where nearly 100% of tumor tissues were shown to carry viral signatures. To get a
broader view on such association, other nearby countries should be investigated. The present study aims to
determine the prevalence and possible associations of the virus in Eritrean breast cancer patients.

EB00000003195K

Available

• Association of Epstein - Barr virus and breast cancer in Eritrea